Alcon Science

Alcon Medical Affairs presents a scientific dinner discussion exploring: Procedural and Pharmaceutical Interventions to Maintain Physiologic Aqueous Outflow in Glaucoma & Multiwavelength Photobiomodulation for the Treatment of Dry Age-Related Macular Degeneration. 📍 Chico Malo, 50 West Jefferson St, Phoenix, AZ 85004 📅 Thursday, June 18, 2026 🕒 6:30 PM (PST) We look forward to an evening of scientific dialogue. ➡️ For more information, register at the Alcon Medical Affairs booth.    For more information, register at the Alcon Medical Affairs booth. This content is intended for healthcare professionals only. The products, services, or offers shown may not be approved or available in every market. Approved labelling and instructions may vary by country. #AOA2026 #Optometry #MedicalAffairs

Join Alcon Medical Affairs for a scientific dinner discussion featuring an overview of Acoltremon Ophthalmic Solution 0.003%. 📍 Mancuso’s Restaurant: 201 E Washington St, Suite 201, Phoenix, AZ 85004 📅 Wednesday, June 17, 2026 🕒 6:30 PM (PST) We look forward to an evening of scientific dialogue. 🔗 Register here: https://lnkd.in/eAhifJyz This content is intended for healthcare professionals only. The products, services, or offers shown may not be approved or available in every market. Approved labelling and instructions may vary by country. #AOA2026 #Optometry #MedicalAffairs

Cataract remains a leading cause of visual impairment globally, with growing demand placing increasing pressure on healthcare systems and surgical capacity. For ophthalmologists, variability in patient pathways, timing of intervention and surgical approach can continue to influence outcomes. This month, we’re engaging with the ophthalmic community to advance cataract care through: 🔬Evidence-led insights into factors influencing outcomes across the cataract pathway 👁️Surgeon perspectives on optimising patient selection, planning and post-operative management ⚙️Advancements in surgical technologies and digital solutions designed to enhance precision, efficiency and consistency 🤝Scientific evidence and clinical experience to support decision-making in practice Explore further clinical insights and resources:👉 https://lnkd.in/e4hXR4NR This content is intended for healthcare professionals only. The products, services, or offers shown may not be approved or available in every market. Approved labelling and instructions may vary by country. #CataractAwarenessMonth #Ophthalmology #EyeCare #MedicalAffairs

Join Alcon Medical Affairs at the American Optometric Association Annual Meeting for a symposium on Real-World Insights With TRYPTYR® (acoltremon ophthalmic solution) 0.003% in Dry Eye Disease. 📍Room 132AB, Phoenix Convention Center, Arizona 📅 Thursday, June 18, 2026 🕒 8:00–9:00 AM (MST) Hear from faculty as they share insights during this scientific discussion: - Dr. Marc Bloomenstein - Dr. Kaleb Abbott - Dr. Ada Noh We look forward to welcoming you for an engaging scientific exchange at AOA. #AOA2026 #Optometry #MedicalAffairs

Alcon Medical Affairs invites you to join our scientific discussions during the American Optometric Association Annual Meeting. 🧬 The presentations will feature: ➡️Surgical - The Role of Valeda PBM in the Treatment of Dry Age-related Macular Degeneration - Wavelight® plus Ray-Tracing Technology LASIK - Clareon® TruPlus: Optical Design and Technology Overview - Clareon PanOptix Pro IOL: Technology 👁️✨ ➡️Glaucoma: - Direct Selective Laser Trabeculoplasty in the Treatment of Open Angle Glaucoma - The Importance of Maintaining Physiologic Aqueous Outflow in Glaucoma - The Spectrum of Surgical to Pharmaceutical Approaches - Netarsudil Efficacy and Tolerability in Black vs. White Individuals: Insights from a Post Hoc Analysis - Effect of the Addition of Netarsudil vs Brimonidine in Normal Tension Glaucoma (NTG) Patients Currently on Latanoprost ➡️Pharma - Acoltremon Ophthalmic Solution 0.003% Overview 📍 Location: Phoenix Convention Center, Arizona. 📅 June 17–20, 2026 📌 Booth #617 We look forward to connecting during the meeting and enabling peer-to-peer scientific discussions. This content is intended for healthcare professionals only. The products, services, or offers shown may not be approved or available in every market. Approved labelling and instructions may vary by country. #AOA2026 #Optometry #MedicalAffairs

We’re pleased to be attending the American Optometric Association Annual Meeting this year in the Phoenix Convention Center at Phoenix, Arizona. 📅 Between June 17–20, our Global Medical Affairs team will be engaging in scientific exchange with the optometric community through a range of discussions and interactions. This is a valuable opportunity to connect, share evidence-based perspectives, and contribute to ongoing dialogue in eye care. We look forward to seeing you there. This content is intended for healthcare professionals only. The products, services, or offers shown may not be approved or available in every market. Approved labelling and instructions may vary by country. #AOA2026 #Optometry #MedicalAffairs

At this year’s APACRS, we’ll be hosting a live Scientific Exchange session focused on the clinical data supporting Clareon® Vivity® and the comparative data vs. PureSee™. The session is designed to advance scientific dialogue, with a focus on understanding how emerging clinical data translate into real‑world decision‑making. Find more below about what you can expect to learn at our Scientific Exchange. We look forward to seeing you there! This content is intended for healthcare professionals only. The products, services, or offers shown may not be approved or available in every market. Approved labelling and instructions may vary by country. #APACRS2026 #Ophthalmology #MedicalAffairs

Join Dr. Rohit Shetty and Dr. Thanapong Somkijrungroj in our new Alcon Science Expert Network program at APACRS. Across 2 sessions, we will be covering the topic of Ray-Tracing-Guided LASIK: Principles and Clinical Outcomes of Vivity® in Special Populations. See below for times and locations. We look forward to seeing you there! This content is intended for healthcare professionals only. The products, services, or offers shown may not be approved or available in every market. Approved labelling and instructions may vary by country. #APACRS2026 #Ophthalmology #MedicalAffairs

Cataract remains a leading cause of vision impairment globally and continues to be under-addressed in many healthcare settings. Progressive opacification of the crystalline lens may initially manifest as changes in visual quality before measurable declines in functional vision, presenting opportunities for earlier clinical recognition and intervention. With an estimated over 94 million individuals affected worldwide, gaps in access to surgical care, timely diagnosis and referral pathways continue to impact patient outcomes. Alcon Science is home to a wealth of the latest evidence-based cataract scientific content, offering insights to inform clinical practice 👉 https://lnkd.in/ejBB9yJF This content is intended for healthcare professionals only. The products, services, or offers shown may not be approved or available in every market. Approved labelling and instructions may vary by country. #CataractAwarenessMonth #Ophthalmology #EyeCare #MedicalAffairs

At this year’s APACRS, you can connect with any of our Medical Science Liaisons at the Alcon booth to request an on‑demand Scientific Exchange discussion tailored to your interests. Simply select which of the 11 topics you’re most interested in learning about from the list below, then visit booth A1 on level 3. We’re excited to meet you all and discuss the innovations shaping the future of eyecare. This content is intended for healthcare professionals only. The products, services, or offers shown may not be approved or available in every market. Approved labelling and instructions may vary by country. #APACRS2026 #Ophthalmology #MedicalAffairs